Today's Daily Dose brings you news about an update on Acasti Pharma's TRILOGY 2 study, Biohaven's disappointing results from Generalized Anxiety Disorder trial, Aquestive Therapeutics' date with FDA, the clinical hold on LogicBio Therapeutics' methylmalonic acidemia trial and Mereo BioPharma's funding transactions.
from RTT - Biotech https://ift.tt/2uCKWBH
via IFTTT
No comments:
Post a Comment